Family Medicine Doctors in La Follette, TN Accepting Medicare

8 Family Medicine doctors found. Showing 1 - 8

Dr. Curtis Cecil Sexton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 Independence Ln, La Follette, TN 37766 Phone: 423-562-1705    Fax: 423-566-3718

Dr. Jacob Robbins, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 923 E Central Ave, La Follette, TN 37766 Phone: 423-907-1200

Kathy M Jackson, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 502 W Central Ave, La Follette, TN 37766 Phone: 423-562-1705

Murugesen Dhandapani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2425 Jacksboro Pike, La Follette, TN 37766 Phone: 423-566-4748    Fax: 423-566-4119

Shaan Valji, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Independence Ln, La Follette, TN 37766 Phone: 423-562-1705    Fax: 423-566-3718

Krista A Bolton, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Independence Ln Ste 200, La Follette, TN 37766 Phone: 423-562-4968    Fax: 423-562-5603

Suzanne M Pearman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2145 Jacksboro Pike, La Follette, TN 37766 Phone: 423-907-1700    Fax: 423-907-1711

Dr. Juliana Williamson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Independence Ln Ste 200, La Follette, TN 37766 Phone: 423-562-4968    Fax: 423-562-5603

News Archive

Myocarditis after SARS-CoV-2 vaccine

A group of Italian researchers has published a study in the Canadian Journal of Cardiology (CJC), that explores a rare case of progressive dyspnea and constrictive retrosternal pain after a SARS-CoV-2 vaccine.

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Research presented at the American Society of Clinical Oncology annual conference suggests that consolidation therapy with tandem compared with single myeloablative autologous stem cell transplant can improve outcomes in paediatric patients with high-risk neuroblastoma.

Medicago, IDRI receive FDA approval to commence Phase 1 H5N1 vaccine trial

The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

Psychiatric inpatients have low vitamin D levels

Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.

Lucideon to run Biodensol together with the University of Lyon

Lucideon is pleased to announce that, together with the University of Lyon, it has been successful in its application to run ‘Biodensol', a 7th framework European project to provide a network for initial training in the field of dentistry.

Read more Medical News

› Verified 2 days ago